ELPA Screening Tour – France, Cyprus, and Germany

As part of the European Liver Screening Tour 2026, France hosted the first stops of ELPA’s major awareness and prevention initiative aimed at promoting early detection of liver disease across Europe. The French leg of the tour took place in Charleville from April 16–19, 2026, offering free, non-invasive liver health screenings to the public and raising awareness about the growing burden of liver disease. The initiative, organised by the European Liver Patients’ Association (ELPA) in collaboration with the local association SOS Hépatite Champagne-Ardenne, forms part of a wider European campaign travelling across six countries in 2026.

The second stop was in Cyprus, from May 7-11, 2026, during the country’s Presidency of the Council of the European Union. Organised in collaboration with the ELPA member Promitheas, the event in Cyprus received strong institutional support, including the participation of the Minister of Health and Member of the European Parliament Hadjipantela, whose presence underscored the growing recognition of liver health as a public health priority at both national and European levels.

The Münster stop of the ELPA Liver Screening Tour (June 9 to 11, 2026) marked the third stop of the 2026 tour in Germany, following successful activities in France and Cyprus.  Organised by ELPA in close partnership with Universitätsklinikum Münster (UKM) and its hepatology team, the screening activities combined early detection with practical education on liver disease prevention, risk factors, and healthy lifestyles.

In each country, media coverage highlighted strong public engagement, with healthcare professionals, patient advocates, and volunteers supporting screening activities and educational outreach.  The Screening Tour also reinforces ELPA’s broader advocacy efforts calling for liver health to become an integral part of European prevention strategies.